$IINN

Tehila Yafit sold $7K of IINN

Tehila Yafit (Chief Financial Officer) sold 1,900 shares of QTREX Quantum Ltd. (IINN) at $3.51 on 2026-05-29 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Tehila Yafit
Published Jun 2, 2026, 8:01 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 2, 2026, 8:11 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$IINN
Neutral
medium confidence
Mentioned
$IINN
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$IINNNeutralLow
01

Why it matters

The disclosed sale may slightly pressure sentiment, but the 10b5-1 plan suggests reduced informational content.

02

Market read

A routine CFO 10b5-1 sale disclosed via Form 4; likely limited incremental trading signal.

03

What to watch

Traders should compare total insider activity over the prior 6–12 months and relate this sale size to overall float/insider holdings; a single Form 4 often lacks standalone predictive power.

Relevance 6/10Novelty 5/10Timing: Filed today; sale occurred 2026-05-29 and is disclosed with a 10b5-1 plan.

Background

The article is an SEC EDGAR Form 4 insider transaction disclosure for QTREX Quantum Ltd. (IINN).

Company-level read

Ticker impact

$IINNNeutralMedium confidence
Context

SEC Form 4 shows CFO Tehila Yafit sold 1,900 IINN shares in an open-market transaction under a 10b5-1 plan.

Expected impact

Low near-term impact; any move is likely sentiment-driven and should be weighed against broader tape/earnings context.

Evidence & confidence

The filing is a routine insider-disclosure datapoint (Form 4) with a stated 10b5-1 plan, which typically dampens interpretive value versus discretionary sales.

Market effects

No sector read-through; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Because the sale is explicitly under a pre-arranged 10b5-1 plan, it may reflect scheduled liquidity rather than negative fundamentals.

Key entities

  • IINN

    Issuer of the securities; subject of the insider transaction disclosure.

  • Tehila Yafit

    Chief Financial Officer who sold 1,900 shares in an open-market transaction under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ATTOLowAI 8/10

GOLDMAN SACHS GROUP INC (WSLS OFFSHORE INVESTMENTS, SLP) purchased $10.3M of ATTO (indirect holdings)

GOLDMAN SACHS GROUP INC purchased 585,000 indirectly-held shares of Attovia Therapeutics, Inc. (ATTO) at an average of $17.58 ($17.00–$21.00, $10.28M total) across 2 trades over 2026-08-05 to 2026-08-06. Filed jointly with GOLDMAN SACHS & CO. LLC, GOLDMAN SACHS ASSET MANAGEMENT, L.P., Broad Street Principal Investments, L.L.C., WSLS OFFSHORE INVESTMENTS, SLP, West Street Life Sciences I, L.P., WSLS EMP OFFSHORE INVESTMENTS, L.P. and WSLS EMP ONSHORE INVESTMENTS, L.P..